Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4635990)

Published in Arthritis Res Ther on November 06, 2015

Authors

Svetlana P Chapoval1,2

Author Affiliations

1: SemaPlex LLC, 3632 Chateau Ridge Drive, Ellicott City, MD, 21042, USA. semaplex@comcast.net.
2: Department of Microbiology and Immunology, Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, 800 West Baltimore Street, Room 301, Baltimore, MD, 21012, USA. semaplex@comcast.net.